Sandbox Reserved 1703: Difference between revisions
No edit summary |
No edit summary |
||
(2 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
=Metabotropic Glutamate Receptor 2= | |||
<StructureSection load='' size='350' frame='true' side='right' caption='Fully Active mGlu2 with G-Protein Bound (PDB: [[7mts]])' scene='90/904307/Main_active_image/2'> | <StructureSection load='' size='350' frame='true' side='right' caption='Fully Active mGlu2 with G-Protein Bound (PDB: [[7mts]])' scene='90/904307/Main_active_image/2'> | ||
Line 36: | Line 36: | ||
====G-protein Binding==== | ====G-protein Binding==== | ||
The PAM induced downward shift of helix 6 coupled with the reorientation of the transmembrane domain to a TM6-TM6 asymmetric interface, opens up a cleft on the intracellular surface of the receptor. This cleft allows a <scene name='90/904308/Hook_region/ | The PAM induced downward shift of helix 6 coupled with the reorientation of the transmembrane domain to a TM6-TM6 asymmetric interface, opens up a cleft on the intracellular surface of the receptor. This cleft allows a <scene name='90/904308/Hook_region/2'>hook-like region</scene>, from terminal 4 residues of the α-subunit of the G-protein to move in adjacent to helix 4 in the TMD. Within this interaction, <scene name='90/904308/Hook_region_recognition/2'>C351</scene> on the hook participates in hydrophobic interactions with ICL2 and helix 4. These interactions allow the C-terminal region of the G-protein α-subunit to bind in the cleft formed by ICL2 and residues on helix 4<ref name="Lin" />.The receptor is now <scene name='90/904307/Main_active_image/4'>fully active</scene> with the dimer coupled only to one G-protein. The VFT is in the closed conformation and the TMD helices are also reoriented in both monomers to form an asymmetric dimer interface. These interactions allow the G-protein to bind which causes mGlu2 to be fully active. Now that mGlu2 is active it can regulate different signaling transductions in the cell<ref name="Lin"/>. | ||
==Clinical Relevance== | ==Clinical Relevance== | ||
Line 48: | Line 48: | ||
[[7mtq]], mGlu2 inactive <br /> | [[7mtq]], mGlu2 inactive <br /> | ||
[[7mtr]], mGlu2 PAM bound <br /> | [[7mtr]], mGlu2 PAM bound <br /> | ||
[[7epe]], mGlu2 NAM bound <br /> | |||
[[7mts]], mGlu2 active <br /> | [[7mts]], mGlu2 active <br /> | ||